211TiPHALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer

211TiPHALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2018-11, Vol.29 (suppl_9)
Hauptverfasser: Oh, D-Y, Park, J-O, Charoentum, C, Stein, S, Noel, M, Chung, V, Wu, W, Alton, R, Muhsin, M, Javle, M, Abou-Alfa, G K, Borad, M J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue suppl_9
container_start_page
container_title Annals of oncology
container_volume 29
creator Oh, D-Y
Park, J-O
Charoentum, C
Stein, S
Noel, M
Chung, V
Wu, W
Alton, R
Muhsin, M
Javle, M
Abou-Alfa, G K
Borad, M J
description
doi_str_mv 10.1093/annonc/mdy432.061
format Article
fullrecord <record><control><sourceid>oup</sourceid><recordid>TN_cdi_oup_primary_10_1093_annonc_mdy432_061</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdy432.061</oup_id><sourcerecordid>10.1093/annonc/mdy432.061</sourcerecordid><originalsourceid>FETCH-oup_primary_10_1093_annonc_mdy432_0613</originalsourceid><addsrcrecordid>eNqVkM9OAjEQhxujifjnAbzNEaIL7S6g642QFUg0bCInL5vZtkBNt91si2Z5a9_AEjh49TKTyXzfTPIj5I7RPqNpMkBjrOGDSrTDJO7TMTsjHTYap9ETHbJz0qFpnESPo2R4Sa6c-6SUjtM47ZCfmLGVyueT1yUwRiNG2TPkW3QSFiU4vxMt2DXk2SyfxxSUAW6rUhn0yhr4Vn4LXLlah9nAPWxkxZXHAEjoBmm6eJ9lbz2wDaCXe6vVfldhCd3JKvtY9oIRiFAD9Ic_LcPFOtyVxrvjJ205at0Cii80XIpBJT06HxgOfGs1mo0KSMOVsRUCGgGbIJQahZAN8IPU3JCLNWonb0_9mjy8ZKvpPLK7uqgbVWHTFowWh1iLY6zFMdYixJr8E_8FavSAUQ</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>211TiPHALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Oh, D-Y ; Park, J-O ; Charoentum, C ; Stein, S ; Noel, M ; Chung, V ; Wu, W ; Alton, R ; Muhsin, M ; Javle, M ; Abou-Alfa, G K ; Borad, M J</creator><creatorcontrib>Oh, D-Y ; Park, J-O ; Charoentum, C ; Stein, S ; Noel, M ; Chung, V ; Wu, W ; Alton, R ; Muhsin, M ; Javle, M ; Abou-Alfa, G K ; Borad, M J</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy432.061</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Annals of oncology, 2018-11, Vol.29 (suppl_9)</ispartof><rights>European Society for Medical Oncology 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Oh, D-Y</creatorcontrib><creatorcontrib>Park, J-O</creatorcontrib><creatorcontrib>Charoentum, C</creatorcontrib><creatorcontrib>Stein, S</creatorcontrib><creatorcontrib>Noel, M</creatorcontrib><creatorcontrib>Chung, V</creatorcontrib><creatorcontrib>Wu, W</creatorcontrib><creatorcontrib>Alton, R</creatorcontrib><creatorcontrib>Muhsin, M</creatorcontrib><creatorcontrib>Javle, M</creatorcontrib><creatorcontrib>Abou-Alfa, G K</creatorcontrib><creatorcontrib>Borad, M J</creatorcontrib><title>211TiPHALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqVkM9OAjEQhxujifjnAbzNEaIL7S6g642QFUg0bCInL5vZtkBNt91si2Z5a9_AEjh49TKTyXzfTPIj5I7RPqNpMkBjrOGDSrTDJO7TMTsjHTYap9ETHbJz0qFpnESPo2R4Sa6c-6SUjtM47ZCfmLGVyueT1yUwRiNG2TPkW3QSFiU4vxMt2DXk2SyfxxSUAW6rUhn0yhr4Vn4LXLlah9nAPWxkxZXHAEjoBmm6eJ9lbz2wDaCXe6vVfldhCd3JKvtY9oIRiFAD9Ic_LcPFOtyVxrvjJ205at0Cii80XIpBJT06HxgOfGs1mo0KSMOVsRUCGgGbIJQahZAN8IPU3JCLNWonb0_9mjy8ZKvpPLK7uqgbVWHTFowWh1iLY6zFMdYixJr8E_8FavSAUQ</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Oh, D-Y</creator><creator>Park, J-O</creator><creator>Charoentum, C</creator><creator>Stein, S</creator><creator>Noel, M</creator><creator>Chung, V</creator><creator>Wu, W</creator><creator>Alton, R</creator><creator>Muhsin, M</creator><creator>Javle, M</creator><creator>Abou-Alfa, G K</creator><creator>Borad, M J</creator><general>Oxford University Press</general><scope/></search><sort><creationdate>20181101</creationdate><title>211TiPHALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer</title><author>Oh, D-Y ; Park, J-O ; Charoentum, C ; Stein, S ; Noel, M ; Chung, V ; Wu, W ; Alton, R ; Muhsin, M ; Javle, M ; Abou-Alfa, G K ; Borad, M J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-oup_primary_10_1093_annonc_mdy432_0613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oh, D-Y</creatorcontrib><creatorcontrib>Park, J-O</creatorcontrib><creatorcontrib>Charoentum, C</creatorcontrib><creatorcontrib>Stein, S</creatorcontrib><creatorcontrib>Noel, M</creatorcontrib><creatorcontrib>Chung, V</creatorcontrib><creatorcontrib>Wu, W</creatorcontrib><creatorcontrib>Alton, R</creatorcontrib><creatorcontrib>Muhsin, M</creatorcontrib><creatorcontrib>Javle, M</creatorcontrib><creatorcontrib>Abou-Alfa, G K</creatorcontrib><creatorcontrib>Borad, M J</creatorcontrib><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oh, D-Y</au><au>Park, J-O</au><au>Charoentum, C</au><au>Stein, S</au><au>Noel, M</au><au>Chung, V</au><au>Wu, W</au><au>Alton, R</au><au>Muhsin, M</au><au>Javle, M</au><au>Abou-Alfa, G K</au><au>Borad, M J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>211TiPHALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer</atitle><jtitle>Annals of oncology</jtitle><date>2018-11-01</date><risdate>2018</risdate><volume>29</volume><issue>suppl_9</issue><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Oxford University Press</pub><doi>10.1093/annonc/mdy432.061</doi></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2018-11, Vol.29 (suppl_9)
issn 0923-7534
1569-8041
language eng
recordid cdi_oup_primary_10_1093_annonc_mdy432_061
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title 211TiPHALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin + gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) + CIS + GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T09%3A00%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=211TiPHALO%20110-101:%20Phase%20Ib%20study%20of%20PEGPH20%20in%20combination%20with%20cisplatin%20+%20gemcitabine%20(PEGCISGEM)%20or%20atezolizumab%20(ATEZO)%20+%20CIS%20+%20GEM%20(PEGCISGEMATEZO)%20in%20patients%20with%20locally%20advanced/metastatic%20cholangiocarcinoma%20and%20gallbladder%20cancer&rft.jtitle=Annals%20of%20oncology&rft.au=Oh,%20D-Y&rft.date=2018-11-01&rft.volume=29&rft.issue=suppl_9&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy432.061&rft_dat=%3Coup%3E10.1093/annonc/mdy432.061%3C/oup%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/annonc/mdy432.061&rfr_iscdi=true